Payment overview · 2025
General Payments
$19.84
1 reported records · 1 companies
Healthcare provider profile · identity verified
Robert Edward Schall, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · HILLSDALE, MI · NPI 1598708638
Verified facts
What the public records show
CMS Open Payments records show Robert Edward Schall, M.D. received $19.84 in general payments during 2025 across 1 reported records.
Inspire Medical Systems, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Inspire Medical Systems, Inc. | Unresolved — no canonical attribution shown | $19.84 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $19.84 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| INSPIRE Normalized: inspire |
Device | Inspire Medical Systems, Inc. | $19.84 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 499 | 143 |
| Omeprazole | Omeprazole | 494 | 127 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 401 | 72 |
| Levothyroxine Sodium | Levothyroxine Sodium | 390 | 101 |
| Atorvastatin Calcium | Atorvastatin Calcium | 349 | 99 |
| Metoprolol Succinate | Metoprolol Succinate | 331 | 95 |
| Lisinopril | Lisinopril | 326 | 89 |
| Losartan Potassium | Losartan Potassium | 298 | 82 |
| Metformin Hcl | Metformin Hcl | 259 | 69 |
| Alprazolam | Alprazolam | 253 | 45 |
| Simvastatin | Simvastatin | 243 | 67 |
| Lovastatin | Lovastatin | 219 | 57 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 187 | 59 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 184 | 48 |
| Gabapentin | Gabapentin | 169 | 45 |
| Hydrochlorothiazide | Hydrochlorothiazide | 160 | 51 |
| Glimepiride | Glimepiride | 159 | 39 |
| Furosemide | Furosemide | 157 | 39 |
| Sertraline Hcl | Sertraline Hcl | 150 | 35 |
| Metoprolol Tartrate | Metoprolol Tartrate | 144 | 43 |
| Montelukast Sodium | Montelukast Sodium | 143 | 37 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 131 | 36 |
| Azithromycin | Azithromycin | 124 | 94 |
| Potassium Chloride | Potassium Chloride | 123 | 37 |
| Clonazepam | Clonazepam | 118 | 23 |
| Clopidogrel | Clopidogrel Bisulfate | 118 | 33 |
| Tamsulosin Hcl | Tamsulosin Hcl | 117 | 37 |
| Prednisone | Prednisone | 106 | 64 |
| Tramadol Hcl | Tramadol Hcl | 105 | 27 |
| Jardiance | Empagliflozin | 102 | 27 |
| Famotidine | Famotidine | 101 | 25 |
| Pantoprazole Sodium | Pantoprazole Sodium | 96 | 32 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 94 | 27 |
| Meloxicam | Meloxicam | 82 | 28 |
| Carvedilol | Carvedilol | 75 | 17 |
| Escitalopram Oxalate | Escitalopram Oxalate | 73 | 17 |
| Ezetimibe | Ezetimibe | 73 | 22 |
| Ventolin Hfa | Albuterol Sulfate | 70 | 16 |
| Fluticasone Propionate | Fluticasone Propionate | 66 | 25 |
| Eliquis | Apixaban | 63 | 16 |
| Pravastatin Sodium | Pravastatin Sodium | 61 | 13 |
| Bupropion Hcl Sr | Bupropion Hcl | 60 | 13 |
| Allopurinol | Allopurinol | 59 | 16 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 56 | suppressed |
| Naproxen | Naproxen | 56 | 17 |
| Atenolol | Atenolol | 55 | 13 |
| Duloxetine Hcl | Duloxetine Hcl | 55 | 17 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 55 | 17 |
| Xarelto | Rivaroxaban | 54 | 13 |
| Cefdinir | Cefdinir | 52 | 44 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 52 | 40 |
| Trazodone Hcl | Trazodone Hcl | 51 | 14 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 50 | 13 |
| Symbicort | Budesonide/Formoterol Fumarate | 49 | 16 |
| Hydrocortisone | Hydrocortisone | 46 | 25 |
| Paroxetine Hcl | Paroxetine Hcl | 45 | 17 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 44 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 43 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 41 | 18 |
| Clonidine Hcl | Clonidine Hcl | 40 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 38 | 28 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 38 | 23 |
| Breo Ellipta | Fluticasone/Vilanterol | 37 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 37 | suppressed |
| Spironolactone | Spironolactone | 37 | 12 |
| Metformin Hcl Er | Metformin Hcl | 36 | 11 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 36 | suppressed |
| Lactulose | Lactulose | 34 | 16 |
| Buspirone Hcl | Buspirone Hcl | 33 | 11 |
| Ibuprofen | Ibuprofen | 33 | 12 |
| Dicyclomine Hcl | Dicyclomine Hcl | 31 | 11 |
| Levetiracetam | Levetiracetam | 31 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 30 | suppressed |
| Pregabalin | Pregabalin | 30 | suppressed |
| Atrovent Hfa | Ipratropium Bromide | 29 | suppressed |
| Bumetanide | Bumetanide | 28 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 27 | 24 |
| Fluoxetine Hcl | Fluoxetine Hcl | 27 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 27 | 22 |
| Cephalexin | Cephalexin | 26 | 21 |
| Incruse Ellipta | Umeclidinium Bromide | 26 | suppressed |
| Temazepam | Temazepam | 26 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 25 | suppressed |
| Synthroid | Levothyroxine Sodium | 24 | suppressed |
| Fluconazole | Fluconazole | 23 | 16 |
| Ondansetron Hcl | Ondansetron Hcl | 23 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 22 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 22 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 22 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 22 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 22 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 21 | suppressed |
| Baclofen | Baclofen | 21 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 21 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 20 | suppressed |
| Aripiprazole | Aripiprazole | 19 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 19 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 19 | suppressed |
| Januvia | Sitagliptin Phosphate | 19 | suppressed |
| Sucralfate | Sucralfate | 19 | suppressed |
| Dulera | Mometasone/Formoterol | 18 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 18 | suppressed |
| Ramipril | Ramipril | 18 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 17 | 12 |
| Oxycodone Hcl | Oxycodone Hcl | 17 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 17 | suppressed |
| Peg-3350 And Electrolytes | Peg3350/Sod Sulf,bicarb,cl/Kcl | 17 | 17 |
| Raloxifene Hcl | Raloxifene Hcl | 17 | suppressed |
| Creon | Lipase/Protease/Amylase | 16 | suppressed |
| Nystatin | Nystatin | 16 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 16 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 15 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 15 | suppressed |
| Glipizide | Glipizide | 15 | suppressed |
| Mirtazapine | Mirtazapine | 15 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 15 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 14 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 14 | suppressed |
| Amoxicillin | Amoxicillin | 14 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 14 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 14 | suppressed |
| Gavilyte-G | Peg3350/Sod Sulf,bicarb,cl/Kcl | 14 | 14 |
| Nortriptyline Hcl | Nortriptyline Hcl | 14 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 13 | suppressed |
| Klor-Con M20 | Potassium Chloride | 13 | suppressed |
| Memantine Hcl | Memantine Hcl | 13 | suppressed |
| Ondansetron Odt | Ondansetron | 13 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 13 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 13 | suppressed |
| Gemfibrozil | Gemfibrozil | 12 | suppressed |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 12 | suppressed |
| Tobramycin | Tobramycin | 12 | 11 |
| Amiodarone Hcl | Amiodarone Hcl | 11 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 11 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 11 | suppressed |
| Fenofibrate | Fenofibrate | 11 | suppressed |
| Finasteride | Finasteride | 11 | suppressed |
| Glipizide Er | Glipizide | 11 | suppressed |
| Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $19.84 · 1 records | Inspire Medical Systems, Inc. | INSPIRE | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error